The type I growth factor receptors in human breast cancer (Q40623955)

22 September 2017

1 reference

title

The type I growth factor receptors in human breast cancer (English)

1 reference

22 September 2017

T Rajkumar

1

1 reference

22 September 2017

W J Gullick

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

Breast Cancer Research and Treatment

22 September 2017

published in

1 reference

22 September 2017

volume

29

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

3-9

1 reference

Expression of the ERBB3 gene product in breast cancer

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00666177

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00666177

Signalling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00666177

c-erbB-2 expression in benign and malignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00666177

c-erbB-2 oncogene as a prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00666177

A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00666177

An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00666177

The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

The type 1 (EGFR-related) family of growth factor receptors and their ligands

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Differential expression of epidermal growth factor-related proteins in human colorectal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Expression of the c-erbB-3 gene product in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Growth factors and oncogenes in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

The molecular biology of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Expression of the c-erbB-3 protein in normal human adult and fetal tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

The erbB-3 gene in human pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7912566

12 December 2020

Identifiers

DOI

10.1007/BF00666177

1 reference

Dimensions Publication ID

22 September 2017

1011645620

0 references

1 reference